chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COLD LIKE SYMPTOMS; UNWELL FEELING; This spontaneous report received from a female patient of unspecified age via a company representative. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced cold like symptoms, and unwell feeling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cold like symptoms, and unwell feeling. This report was non-serious.
patients tongue swelled and felt numb.  Eye felt swollen and had a tickle in her throat. EMS gave her benadryl
Case number PHEH2015US021306, is an initial spontaneous report received from a consumer (patient) on 19 Oct 2015. This report refers to a 33 year old female patient. Medical history and concomitant medication was not reported. The patient reported that she could be pregnant and received FLUVIRIN (batch number: 1515801) intramuscular on 19 Oct 2015. No adverse event was reported.
Dizziness, Headache, Arthralgia, shortness of breath Narrative:  Employee reports "instant headache" after receiving 2nd dose of vaccine. Also reports joint pain, dizziness, and shortness of breath. Of note, employee has a history of asthma. Reports using ibuprofen, Tylenol, and asthma inhaler (name of medication not specified) for symptoms.
Expired COVID-19 vaccine given to patient. COVID vaccine lot FL2757 expired 09/30/2022 (also thawed on 09/30/2022) and was given  on 10/5/2022.  no adverse events reported.
A initial report received on 20/Jan/2006 from a health care professional. A female patient (date of birth not reported) had received an administration (route not reported) of DIPHYTHERIA AND TETANUS TOXOIDS (lot number not reported), in the left arm and an administration (route not reported) of FLUZONE SV '2005-'2006 USP (lot number not reported), in the right arm on 09/Jan/2006. At an unspecified time later, the patient developed a "baseball size lump" to the left arm at the injection site that was hot to touch and red. Patient was unable to bend the elbow on the left arm. She also developed a fever and "flu-like" symptoms that lasted four days. At the time of this report, the arm had a one and a half centimeter hard, red area and the patient had not fully covered. Follow-up information received on 20/Mar/2006. Per reported, the patient last had tetanus/diptheria vaccination  ten years ago. Patient has no pre-existing allergies or medical conditions and denies being on any concomitant medication  or having any illnesses at the time of vaccination. The patient received the intramuscular injection of Decavac, lot number 01703CA (expiry date 11/Jul/2007) in the left arm, the intramuscular injection of Fluzone, lot number U1935AA (expiry date 30/Jun/2006) in the right arm, the intramuscular injection of the second dose of Hepatitis B Vaccine, lot number 0336R, (site not reported) and the subcutaneous injection of MMR, lot number 0295R (site not reported) on 09/Jan/2006 at 7 AM. It was also reported the patient received the intramuscular injection of the first dose of Hepatitis B Vaccine, lot number 0336R (date received not reported) within four weeks prior the vaccines received on 09/Jan/2006. The patient's fever began at approximately 7:30-8:00 PM on 09/Jan/2006 along with arm soreness. The next morning the patient's arm was very sore and progressively got more painful with redness and swelling. By evening she could hardly lift her arm or grip the steering wheel. It "swelled to the size of softball" which could actually be seen through the patient's clothing. The arm felt very warm and tender with touch. Also, very painful to lift or move. Almost had a "bullseye" appearance. Fever of 101 began approximately eight hours after injection and continued for 24 hours. On 19/Jan/2006 when this report was made there was still a 1 1/2 diameter raided hard bump that appears to be "sunburned". The patient was seen by the physician on 20/Jan/2006. No diagnostic tests or laboratory data was performed. Per reporter, the patient recovered. No further information expected.
PATIENT EXPERIENCED PAIN AND IMMOBILITY IN THE ARM ABOUT ONE HOUR AFTER RECEIVING VACCINATION. HER PHYSICIAN PRESCRIBED PHYSICAL THERAPY DUE TO VACCINATION BE GIVEN TOO HIGH ON THE ARM INTO SHOULDER TENDON.
patient received shot on 12/10/2021 in the evening. patient woke up on 12/11/2021 and had developed a lump under her armpit. claims it is about 4 in wide and is painful. she had the lump for 5 days before reporting and it had not gotten worse or better from when it developed.
7 days after recieving the first Moderna Covid shot I began having palpitaions daily, rather disturbing palpitaions at first onset and then milder palpitations that became less frequent throughout the next three weeks.,  I began to have bad headaches daily. The headaches were strong enough that I had to take advil and tylenol every day for several doses throughout the day. The headaches became less strong but lasted also about three weeks.  I have not had another injection. I felt awful for three weeks and think something happened inside my brain.
Pfizer-BioNTech COVID-19 Vaccine EUA Pain at injection site (left arm) within 1 hour of being bitten twice on left hand by unknown insect(s) while gardening.  Bites were raised, red, extremely itchy, with allergic ring around them.  Left arm pain was intense x 18 hours then just painful to touch.
21 hrs after receiving 3 vaccines, developed urticarial eruption, which was associated w/core temp 99.2. Became generalized, child taken to ER & given Benadryl. Took this for 8 days, rash resolved. Dx in ER was multiforme. No inc in temp.
pt recvd vax & mins later collapsed; dec pulse; B/P approx 100 systolic; began to have n; v; epi given; systolic BP 70; 1 hr later, v, n reoccured; given epi; admitted to hosp; MD believes anaphylaxis secondary to vax;
Extreme headache like pain untouched by any at home, over the counter or prescription migraine medicines.  After 4 days I finally went to Urgent Care where I was given a toradol shot that  eased the pain enough that I was able to sleep but only to wake the next morning in the same agony.  I had a televisit with my primary physician who called in Tramadol and told me to alternate it with Tylenol. Finally after 3 days of alternating my pain was gone.
DTaP-IPV portion of Pentacel given instead of Daptacel.
PAIN IN BASE OF SKULL/NECK; COUGHED UP MUCUS; FELT HOT; ACHY BACK AND SHOULDERS; FELT LIKE SINUS INFECTION AROUND MY EYES/FOREHEAD; FELT SICK, UNWELL; HEADACHE; NAUSEA ON AND OFF; BODY TEMPERATURE OF 97.6F; A LITTLE STUFFINESS; EXTRA AWARE FEELING; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included anaphylactic to bee stings, and allergy to pollen. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: 13-JUN-2021) dose was not reported, administered on 27-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 27-APR-2021, the subject experienced extra aware feeling. On 28-APR-2021, the subject experienced a little stuffiness. On MAY-2021, Laboratory data included: Body temperature (NR: not provided) 97.6 F. On 04-MAY-2021, the subject experienced pain in base of skull/neck. On 04-MAY-2021, the subject experienced coughed up mucus. On 04-MAY-2021, the subject experienced felt hot. On 04-MAY-2021, the subject experienced achy back and shoulders. On 04-MAY-2021, the subject experienced felt like sinus infection around my eyes/forehead. On 04-MAY-2021, the subject experienced felt sick, unwell. On 04-MAY-2021, the subject experienced headache. On 04-MAY-2021, the subject experienced nausea on and off. On 04-MAY-2021, the subject experienced body temperature of 97.6f. Treatment medications (dates unspecified) included: arnica montana, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from extra aware feeling on 27-APR-2021, a little stuffiness on 29-APR-2021, and coughed up mucus on 05-MAY-2021, was recovering from felt sick, unwell, headache, pain in base of skull/neck, nausea on and off, achy back and shoulders, and felt like sinus infection around my eyes/forehead, and the outcome of felt hot and body temperature of 97.6f was not reported. This report was non-serious.
pt rcvd vax; pt devel arthralgia 3wks following vax; some myalgias w/ 1st dose; pt rcvd 2nd dose & symptoms persisted;
C/o fullness in throat - taste of metal in her mouth - itching feeling inside of mouth - lips feeling numb.
No reported adverse reaction reported. The recommended time between the first and second vaccination  per manufacturer is 8 weeks and the second vaccination was 6 weeks apart. After calling GlaxoSmithKline they said because the second dose was given after at least 4 weeks that it was a valid vaccination
One week after second dose: intense fatigue and mental fog, leg weakness, generalized muscle pain and weakness, mood alteration (intermittent and recurrent) Then 3 months after 2nd dose severe photodermatosis and  hyperparesthesia with sensation of burning skin, unable to stand sunlight without immediate development of painful rash, tiredness,
I felt my heart beat in an irregular pattern (AFib) and even it detected  by Watch.; I felt my heart beat in an irregular pattern (AFib) and even it detected  by Watch.; Date of start of drug: 01May2021, Dose Number: 1; Date of start of drug: 01May2021, Dose Number: 2; Date of start of drug: 01May2021, Dose Number: 1; Date of start of drug: 01May2021, Dose Number: 2; This is a spontaneous report from a contactable female consumer reported for herself. A 32-year-old (non-pregnant) female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0171, Expiration date: unknown), via unspecified route, administered in left arm on 01May2021 at 11:15 AM (at the age of 32-year-old) as 1st dose, single dose for COVID-19 immunisation. On the same day(01May2021), the patient received another dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0179, Expiration date: unknown), via unspecified route, administered in left arm on 01May2021 at (at the age of 32-year-old) as 2nd dose, single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no history of allergies. No other vaccines were received within 4 weeks prior to Covid vaccine. Prior or post vaccination the patient has not been tested or diagnosed with covid 19. On 23May2021, at 11:45 am, 22 days after the vaccination, the patient experienced heartbeat in irregular pattern (AFib) and even it detected by her watch. The lab data includes heart rate monitoring on 23May2021. No treatment options were used for the event. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.
severe fever after 7 hours-103-104 lasted 11 hours-reduced fever 15 more hours, chills, accelerated pulse, rapid breathing, nausea-no food or water 15 hours, enlarged lymph gland under right jaw  (did notice an enhanced sense of smell during both 1st and 2nd shot reaction period)
On 10/27/99, pt developed paresthesias, weakness and an injection site reaction characterized by a rash and pain that extended down her arm and up into her neck. She recovered from the rash and paresthesia; however, as of 11/5/99, the pain and weakness persisted.
I had a red itchy area on my leg that was itchy and blistered that eventually popped and had a clear liquid. I did not have a fever or pain with it so I decided to wait and see what would happen. I was concerned because it took five days to resolve so I called the nurses line and was advised to use gauze to cover the area to help keep it from rubbing against my clothing or when I stood beside the bed. When I had a home visit from my Nurse Practitioner, I showed her the pictures of my leg that had now healed. She said from the look of pictures, it could have been shingles.
This spontaneous report was received from a consumer referring herself as a female patient of currently 80 years old. The patient concurrent conditions included shingles, high blood pressure and hypothyroidism. The patient's medical history was not reported. The patient was allergic to latex and penicillin. The patient's concomitant medication included losartan and levothyroxine. On an unknown date, approximately back in 2006 to 2007, the patient was vaccinated with ZOSTAVAX (0.65 ml, frequency not reported) (lot# and expiration date not reported) subcutaneously. On an unknown date, reported as within a year of getting vaccination, the patient experienced dizzy spells (dizziness), blood pressure went up like crazy (blood pressure increased) and had pins and needles in both of feet, middle of back and down of arms and hands. It was also reported that, the patient was in constant pain and reported that it was been horror (pain). The patient have seen multiple neurologists and given with couple of unspecified shots in back to numb it, but patient was suffering. The patient received tramadol for pain, but patient got violently ill with vomiting and dizziness and stopped taking it. Patient also stated that, unspecified blood tests and echocardiogram were performed to the patient, but results were not provided. The patient was not recovered from the events. The reporter did not provide the causal relationship for the events with suspect therapy ZOSTAVAX. No product quality complaint was involved.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 15-NOV-2015 at time- 18:13, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 3.1 and 2.5 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
got the shots-got the shingles/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the Shingles shots and got the shingles.  The patient stated that the shingles was not as bad as some, so they say was awful. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Information has been received from a certified nurse practitioner concerning a 22 year old female with overactive bladder and allergies and no illness at the time of vaccination , who on 20-Mar-2009 and 22-May-2009 was vaccinated into the left deltoid with first dose (lot number reported as 13124, not valid) and second dose (lot number reported as U5581, not valid) respectively of GARDASIL. Concomitant therapy included FLONASE, ZYRTEC, birth control pills and DETROL LA. Four days after vaccination on 26-May-2009, the patient had a bald spot on head, she denied change in any medications. It was reported that nothing else was different. Additional information has been requested.
I failed to reconstitute the vaccine with the adjuvant suspension component. Patient only received the adjuvant suspension component.
3 minute stiffenig of body and arching of back. rolling eyes and dusky color. ? seizure activity
Pt itching on scalp, thighs, chest and right arm, hives to right forearm. Gave pt 50mg IM Benadryl to left deltoid
Pain, numbness and swelling at the injection site. Second day: hot red area of about 3 inches developed below the injection site. More severe swelling and pain followed. The muscle became hard. Is not getting better after three days. More red blotches developed below the injection site that were not connected to the original redness.
Information has been received from a physician concerning a 71 year old male patient with coeliac disease, recurring rash and dermatitis herperatormis, who in 2008 was vaccinated with a dose of ZOSTAVAX (Merck), 0.65 ml (route and lot # not reported). It was reported that, in 2008, within a week of the vaccination, the patient started experiencing severe left extremity pain. It was also reported that the patient had been experiencing the pain intermittently since then. The patient stated he had recurring rash and dermatitis herperatormis, which he got because of celiac disease. He was getting this rash before and after the pain started. The patient was put on acyclovir (date and manufacturer not reported) which helped with the pain. His treatment also included dapsone (unspecified). At the time of the report, the patient's outcome was recovering. Follow up information has been received from a physician concerning a 68 year old retired male patient with coeliac disease treated with diet, who on 28-MAY-2008, was vaccinated with a dose of ZOSTAVAX (Merck), 0.65 ml, subcutaneously into left arm (lot # 659614/0161X, expiration date 11-JUL-2009). No immediate local reaction was reported. 1 week later, on 03-JUL-2008, the patient developed severe radicular pain into left arm that required multiple admissions for pain control. No rash or local injection reaction was noted. It was reported that on an unknown date, electromyogram (EMG) and nuclear magnetic resonance imaging (MRI) were performed and showed cervical spine unremarkable. The patient was treated with gabapentin with some relief. In April 2012 the patient had hair up of pain and another physician gave him acyclovir 800 mg four times a day. No rash noted and pain resolved totally in 24 hours. The patient finished 1 week of acyclovir and pain recurred within few days. It was also reported that the patient was placed on low dose (400 mg) of acyclovir daily and pain resolved completely with continuous use. Acyclovir was stopped temporarily in June while having surgery and pain recurred again. Then the patient was back on continuous acyclovir 400 mg daily and felt very comfortable. At the time of the report the patient recovered. Additional information is not expected.
After first dose patient hospitalized for RDS/ pneumonia, complicated hospitalization due to sudden CVA. Then to nursing home for rehab.  Second dose done months later and next day, hospitalized- heart failure, RDS.  complicated rehabilitation.  Two hospitalizations both ocurred within 24 hours of vaccine.  Died in her sleep suddenly at SNF.  Initial and Second Acute care Stay both began within 24 hr after vaccine doses.  Sudden unexpected death in September at SNF.   Likely related to patients with Factor V Leiden defect should not receive these vaccines.
Chest Pain severe to the point that I went to the Emergency Room.  By the time I got there pain subsided.  EKG and bloodwork normal. Feel OK today
chills; fever; injection site reaction; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: Not reported), via an unspecified route of administration on an unspecified date, as first dose, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date of 2021, the patient experienced chills, fever and injection site reaction, but chills well after second dose which was on 28Apr2021. The outcome was recovered for chills on an unspecified date of 2021 and unknown for rest of the events.  Information about Lot/Batch number has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Jan2021 as dose 1, single (Lot number: EK9231), in left arm, on 01Feb2021 as dose 2, single (Lot number: EL8982), in left arm and on 29Sep2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 69 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Hashimoto's" (unspecified if ongoing); "GERD" (unspecified if ongoing); "Osteoporosis" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; WELLBUTRIN; AMLODIPINE; PROLIA.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of covid-19.  Clinical information: Known allergies: No.Anti viral details: product=COVID 19 Treatment, brand=Paxlovid, Treatment start date=09Apr2022, treatment stop date=11Apr2022.  No follow up attempts possible. No further information Is expected.; Sender's Comments: Based on the available information, there is a reasonable possibility of a causal relationship between the suspect vaccine BNT162B2 (COMIRNATY) and reported events Vaccination failure and COVID - 19 which cannot be fully assessed/excluded. The case will be reassessed if additional information becomes available.
Throughout the night following the injection, difficulting sleeping due to severe and prolonged shivering (and what appeared to be feverish when no shivering) along with intense pain in left hip, and other pain throughout.  The next morning I was achy all over and felt as if I had the flu but without the "head/nasal" symptoms.